drug,target
Alectinib,ALK
Brigatinib,ALK
Dacomitinib,EGFR;ERBB2;ERBB4
Lorlatinib,ROS1;ALK
Mobocertinib,EGFR
Sotorasib,KRAS
Tepotinib,MET
Capmatinib,MET
Osimertinib,EGFR
Tepotinib,MET
Ceritinib,ALK





